Sign in

Terrence W. Cavanaugh

Director at SELECTIVE INSURANCE GROUPSELECTIVE INSURANCE GROUP
Board

About Terrence W. Cavanaugh

Independent director of Selective Insurance Group since 2018; age 71. Founding partner at Accretive Consulting (since 2017), former President & CEO of Erie Indemnity (2008–2016), and long-tenured Chubb executive (1975–2007). Education: B.B.A., University of Notre Dame; Program for Management Development, Harvard Business School. Core credentials include >40 years of P&C insurance leadership, distribution, underwriting/operations, risk management, and talent development .

Past Roles

OrganizationRoleTenureCommittees/Impact
Accretive Consulting LLCFounding Partner2017–presentAdvisory work leveraging insurance growth and distribution expertise
Erie Indemnity CompanyPresident & CEO2008–2016Led Fortune 500 insurer; growth in DPW and surplus, profitability, agent relationships
Chubb GroupCOO, Surety & Trade Credit; CMO; underwriting/field roles1975–2007Operations, marketing, underwriting leadership across segments
Insurance Information InstituteChair; Director2011–2016 (Chair 2015–2016)Industry thought leadership and public disclosure expertise
Property Casualty Insurance AssociationChair; Director2008–2017 (Chair 2014–2015)Industry advocacy, risk and regulatory engagement

External Roles

OrganizationRoleTenureNotes
Highmark HealthDirector2013–presentHealth sector board service (not a public P&C competitor)
Naples Airport AuthorityBoard of Commissioners2022–presentLocal government oversight of airport operations
The InstitutesTrustee2010–2016Insurance credentialing and education influence

Board Governance

  • Committee memberships: Audit Committee member; Risk Committee member. Not a chair; Audit Chair is H. Elizabeth Mitchell, Risk Chair is John S. Scheid .
  • Independence: Board determined he is independent under Nasdaq/SEC rules; all members of Audit and Risk Committees are independent .
  • Attendance: Board held 7 meetings in 2024; independent directors met 4 times without management. All directors attended at least 75% of aggregate Board/committee meetings; average attendance >98%; all then-serving directors attended the 2024 annual meeting .
  • Lead independent director: Robert Kelly Doherty (since 2022) .
  • Board refreshment/retirement: Mandatory director retirement age is 72; Cavanaugh is 71, indicating approaching age-based turnover consideration .

Fixed Compensation

Component2024 AmountDetails
Annual Retainer$100,074Directors can elect stock; Cavanaugh elected to take 1,038 shares valued at $100,074
Annual Equity Grant (RSUs)$110,004Unvested RSUs at year-end: 1,141 units; grant under 2024 Omnibus Stock Plan
Committee Chair Fees$0Not a chair; Audit Chair $35k, Risk Chair $25k (program terms)
Committee Member Fees$0SIGI pays member fees only for a third committee ($8k); Cavanaugh serves on two
Total 2024 Director Pay$210,078Fees + stock awards

Performance Compensation

  • Directors do not receive performance-based awards; annual equity is RSUs with service-based vesting. No options or performance metrics disclosed for director equity .

Other Directorships & Interlocks

Company/EntityPublic Company?Potential Interlock/ConflictNotes
Highmark HealthNo (non-profit health)LowNot overlapping with SIGI’s P&C footprint
Naples Airport AuthorityNoLowGovernment board role
Industry associations (III, PCI)NoLowPrior industry associations, no current related-party exposure disclosed

No specific related-party transactions or independence exceptions disclosed for Cavanaugh; Board independence review flagged other directors (Doherty, Mitchell, Sampson), not Cavanaugh .

Expertise & Qualifications

  • Insurance industry, risk management, financial statement/audit/public disclosure, finance/capital management/M&A, investment, agency distribution, technology/cybersecurity, legal/regulatory, marketing/branding, human capital management .

Equity Ownership

MetricValueNotes
Beneficial ownership (2/20/2025)20,659 sharesLess than 1% of class; no margin pledging or pledged shares
Director RSUs unvested (12/31/2024)1,141 unitsProgram RSUs for directors
Insider trades (Form 4)1,000 shares bought @ $98.47 (2/2/2024) ; 2,000 shares bought @ $85.85 (7/23/2024) ; 2,000 shares bought @ $75.72 (7/25/2025)
Ownership guidelines5x annual retainer; all directors met or are on trackCompany-wide disclosure; no individual shortfall noted
Hedging/pledging policyHedging prohibited; pledging oversight by CHCCCompany policy prohibits hedging; CHCC oversees pledging policy

Governance Assessment

  • Committee effectiveness: Placement on Audit and Risk signals Board reliance on his financial reporting, disclosure, and enterprise risk oversight experience; not over-concentrated (no chair role), which mitigates key-person risk .
  • Independence & conflicts: Confirmed independent; no Cavanaugh-specific related-party exposures disclosed; company’s Related Person Policy routes approvals through the Audit Committee and prohibits conflicted members from participating .
  • Engagement: Strong Board-wide attendance (>98% average); all directors ≥75% threshold; Cavanaugh’s insider purchases in 2024–2025 are a positive alignment signal (skin-in-the-game) .
  • Compensation alignment: Director pay mix of retainer and RSUs, with option to take retainer in stock (which Cavanaugh did), supports ownership and alignment; absence of option grants or performance pay reduces pay-for-performance leverage but is consistent with director governance norms .
  • RED FLAGS: None disclosed (no pledging, no related-party transactions tied to Cavanaugh, no attendance issues). Watchlist item: mandatory retirement age 72 suggests potential near-term Board turnover and succession planning need for Audit/Risk bench strength .

Board Governance (Program Overview)

ItemPractice
Majority voting for directorsResignation required if not receiving majority in uncontested elections; CG&N Committee reviews; Board acts within 90 days
Executive sessionsIndependents met 4 times in 2024
Overboarding limitsMax 4 public boards (2 if CEO) with pre-clearance for conflicts/time demands
Clawback policyDodd-Frank compliant, mandatory recoupment on restatements; effective Dec 1, 2023
Say-on-pay support2024 approval >99% of votes cast (climate of shareholder support)

Director Compensation (Program)

TypeAmountNotes
Annual Retainer$100,000Cash or stock election
Annual RSU grant$110,000Under 2024 Omnibus Stock Plan
Committee chair fees$25,000–$35,000Audit $35k; Risk $25k; Finance & Investments $35k; CG&N $25k; CHCC $25k
Third committee member fee$8,000No fees for first two committees
Lead Independent Director$40,000Separate fee

Related Party Transactions (Policy Context)

Audit Committee pre-approves related-party transactions; conflicted members recuse; reviews benefit to Selective, independence impacts, terms vs third parties. 2024 disclosures focus on large holders (BlackRock, Vanguard, Fidelity) and fund services; none attribute transactions to Cavanaugh .

Equity Ownership (Detail)

HolderShares (2/20/2025)% of ClassNotes
Terrence W. Cavanaugh20,659*Less than 1%; no options exercisable; no RSUs vesting within 60 days; no pledging/margin
Unvested RSUs (12/31/2024)1,141N/ADirector RSUs per program

Insider Trades (Recent)

DateActionSharesPriceSource
2024-02-02Purchase1,000$98.47
2024-07-23Purchase2,000$85.85
2025-07-25Purchase2,000$75.72

Governance Assessment Summary

  • Strengths: Deep insurance expertise deployed on Audit and Risk; independent, engaged, with positive insider buying; compensation and equity design promote alignment; robust corporate governance (majority voting, clawback, hedging ban, overboarding limits) .
  • Watch items: Approaching mandatory retirement age could necessitate succession for risk/audit competencies; continued monitoring of insider ownership growth vs director ownership guidelines (company says all directors met/on-track) .
  • No identified conflicts or red flags tied to Cavanaugh in 2024–2025 disclosures .